The Role of MAOA Gene in the Etiology of Autism Spectrum Disorder in Males

Authors: Jana Kisková, Dana Gabriková

Abstract:

Monoamine oxidase A gene (MAOA) is suggested to be a candidate gene implicated in many neuropsychiatric disorders, including autism spectrum disorder (ASD). This meta-analytic review evaluates the relationship between ASD and MAOA markers such as 30 bp variable number tandem repeats in the promoter region (uVNTR) and single nucleotide polymorphisms (SNPs) by using findings from recently published studies. It seems that in Caucasian males, the risk of developing ASD increase with the presence of 4- repeat allele in the promoter region of MAOA gene whereas no differences were found between autistic patients and controls in Egyptian, West Bengal and Korean population. Some studies point to the importance of specific haplotype groups of SNPs and interaction of MAOA with others genes (e. g. FOXP2 or SRY). The results of existing studies are insufficient and further research is needed.

Keywords: Autism spectrum disorder, MAOA, uVNTR, single nucleotide polymorphism.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1338070

References:

[1] American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, Arlington, VA: American Psychiatric Publishing, 2000.
[2] S. Chakrabarti, and E. Fombonne, “Pervasive developmental disorders in preschool children: confirmation of high prevalence,” Am. J. Psychiatry, vol. 162, no. 6, pp. 1133–1141, Jun. 2005.
[3] R. J. Landa, K.. C. Holman and E. Garrett-Mayer, “Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders,” Arch. Gen. Psychiatry, vol. 64, no. 7, pp. 853–864, Jul. 2007.
[4] C. A. Pardo, and C. G. Eberhart, “The neurobiology of autism,” Brain. Pathol., vol. 17, no. 4, pp. 434–47, Oct. 2007.
[5] J. M. Berg, and D. H. Geschwind, “Autism genetics: searching for specificity and convergence,” Genome Biol., vol. 13, no. 7, pp. 247, Jul. 2012.
[6] K. S. Lam, M. G. Aman, and L. E. Arnold, “Neurochemical correlates of autistic disorder: A review of the literature,” Res. Dev. Disabil., vol. 27, no. 3, pp. 254–289, May-Jun. 2006.
[7] S. Z. Sabol, S. Hu, and D. Hamer, “A functional polymorphism in the monoamine oxidase A gene promoter,” Hum. Genet., vol. 103, no. 3, pp. 273–279, Sep. 1998.
[8] J. Samochowiec, A. Hajduk, A. Samochowiec, J. Horodnicki, G. Stepien, A. Grzywacz, et al., “Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum,” Psychiatry Res., vol. 128, no. 1, pp. 21–26, Aug. 2004.
[9] L. Passamonti, F. Fera, A. Margariello, A. Cerasa, M. C. Gioia, M. Muglia, et al., “Monoamine oxidase-A genetic variations influence brain activity associated with inhibitory control: New insight into the neural correlates of impulsivity,” Biol. Psychiatry, vol. 59, no. 4, pp. 334–340, Feb. 2006.
[10] T. Banaschewski, K. Becker, S. Scherag, B. Franke, and D. Coghill, “Molecular genetics of attention-deficit/hyperactivity disorder: an overview,” Eur. Child. Adolesc. Psychiatry, vol. 19, no. 3, pp. 237–257, Mar. 2010.
[11] I. L. Cohen, X. Liu, M. E. S. Lewis, A. Chudley, C. Forster-Gibson, M. Gonzalez, et al., “Autism severity is associated with child and maternal MAOA genotypes,” Clin. Genet., vol. 79, no. 4, pp. 355–362, Apr. 2011.
[12] F. Tassone, L. Qi, W. Zhang, R. L Hansen, I. N Pessah, and I. Hertz- Picciotto, “MAOA, DBH and SLC6A4 variants in CHARGE: A case control study of autism spectrum disorders,” Autism. Res., vol. 4, no. 4, pp. 250–261, Aug. 2011.
[13] J. Roohi, C. J. DeVincent, E. Hatchwell, and K. D. Gadow, “Association of a monoamine oxidase-A gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder,” J. Autism. Dev. Disord., vol. 39, no. 1, pp. 67–74, Jan. 2009.
[14] D. Hranilović, R. Novak, M. Babić, M. Novokmet, Z. Bujas-Petković and B. Jernej, “Hyperserotonemia in autism: The potential role of 5HTrelated gene variants,” Coll. Antropol., vol. 32, Suppl. 1, pp. 75–80, Jan. 2008.
[15] L. K. Davis, H. C. Hazlett, A. L. Librant, P. Nopoulos, V. C. Sheffield, J. Piven, et al., “Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene,” Am. J. Med. Genet. B Neuropsychiatr. Genet., vol. 147B, no. 7, pp.1145–1151, Oct. 2008.
[16] D. Verma, B. Chakraborti, A. Karmakar, T. Bandyopadhyay, A. S. Singh, S. Sinha, et al., “Sexual dimorphic effect in the genetic association of monoamine oxidase A (MAOA) markers with autism spectrum disorder,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 50, pp. 11–20, Apr. 2014.
[17] A. M. Salem, S. Ismail, W. A. Zarouk, O. Abdul Baky, A. A. Sayed, S. Abd El-Hamid, et. al., “Genetic variants of neurotransmitter-related genes and miRNAs in Egyptian autistic patients,” ScientificWorldJournal, 2013: ID 670621, Dec. 2013.
[18] H. J. Yoo, S. K. Lee, M. Park, I. H. Cho, S. H. Hyun, J. C. Lee, et al., “Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean,” Neurosci. Res., vol 63, no. 3, pp. 172–176, Mar. 2009.
[19] Y. Park, S. Won, M. Nam, J. H. Chung, and K. Kwack, “Interaction between MAOA and FOXP2 in association with autism and verbal communication in Korean population (Epub ahead of print),” J. Child. Neurol., Dec. 2013.
[20] C. S. Lai, S. E. Fisher, J. A. Hurst, F. Vargha-Khadem, and A. P. Monaco, “A forkhead-domain gene is mutated in a severe speech and language disorder,” Nature, vol. 413, no. 6855, pp. 519-523, Oct. 2001.
[21] K. D. MacDermot, E. Bonora, N. Sykes, A. M. Coupe, C. S. Lai, S. C. Vernes, et al., “Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits,” Am. J. Hum. Genet., vol. 76, no. 6, pp.1074-1080, Jun. 2005.
[22] J. B. Wu, K. Chen, Y. Li, Y. F. Lau, and J. C. Shih, “Regulation of monoamine oxidase A by the SRY gene on the Y chromosome,” FASEB J., vol. 23, no. 11, pp. 4029–38, Nov. 2009.